Simon Quick Advisors, LLC Repligen Corp Transaction History

Simon Quick Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$140.68 - $188.02 $10,691 - $14,289	-76 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$247.59 - $304.47 $12,874 - $15,832	-52 Reduced 40.63%	76 $20,000
Q3 2021 Oct 27, 2021	BUY	$194.77 - $324.21 $10,128 - $16,858	52 Added 68.42%	128 $36,000
Q4 2020 Jan 27, 2021	BUY	$148.08 - $206.57 $11,254 - $15,699	76 New	76 $15,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Simon Quick Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Simon Quick Advisors, LLC with notifications on news.